Skip to main content
editorial
. 2014 Feb 28;13(7):1053–1054. doi: 10.4161/cc.28377

graphic file with name cc-13-1053-g1.jpg

Figure 1. mTORC2 is a kingpin of the Warburg effect and drug resistance. mTORC2 inhibits FoxO via acetylation, whereas PI3K/Akt via phosphorylation, leading to the upregulation of c-Myc, a key effector of the Warburg effect. PI3K/Akt-targeted therapies alone can be bypassed by mTORC2-mediated pathways, whereas targeting both PI3K/Akt and mTORC2 potently suppresses c-Myc and the Warburg effect.